Atezolizumab trials for Prostate cancer

All Atezolizumab trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Atezolizumab for Prostate cancer

• A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
  NCT05652686 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
  NCT05000294 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
  NCT05168618 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
  NCT04812366 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 9 locations
• Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
  NCT03821246 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations

Common questions

How many trials study Atezolizumab for Prostate cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.